The Trump administration will require pharma companies to disclose the list prices of drugs in direct-to-consumer ads. More details around the requirement could come as soon as today, when HHS Secretary Alex Azar delivers a scheduled speech on drug pricing reforms. The PhRMA trade group is also planning an announcement on the subject this morning. (Politico)
The FDA set a generic drug approval record in 2016. The agency racked up 651 approvals (835, if you count tentative approvals), up by 159 and 242 from 2015 and 2014, respectively. (RAPS)
A new study reveals how easy it is to identify someone through a genealogy website — regardless of whether they’ve submitted their DNA. (Science) Researchers were able to find third cousins for more than half of the study’s participants, information that could, in many cases, be used to track down their identity. (The New York Times)
Even as they condemn drug distributors, lawmakers are accepting money from them. AmerisourceBergen, Cardinal, and McKesson have donated nearly $3 million to the 2017-18 campaign cycle, with most of the money going to lawmakers who sit on committees with regulatory oversight. (STAT)
The FDA is cracking down on electronic cigarette manufacturers. The agency has sent 21 letters to companies, requesting documents that prove they sold the products before August 2016 (the date in which the FDA banned the sale of new e-cigarette products). (Reuters)
